`
`________________________
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`________________________
`
`
`DR. REDDY’S LABORATORIES S.A. AND
`DR. REDDY’S LABORATORIES, INC.
`Petitioners,
`
`v.
`
`INDIVIOR UK LIMITED.
`Patent Owner.
`
`________________________
`
`
`IPR2019-00329
`Patent 9,687,454
`
`________________________
`
`
`PATENT OWNER UPDATED EXHIBIT LIST
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`IPR2019-00329
`Patent 9,687,454
`
`
`Exhibit No. Description
`Ex. 2001 Declaration of Dr. Karsten Cremer, Ph.D.
`
`Ex. 2002 WO 2009/012590
`
`Ex. 2003 U.S. Patent No. 5,845,481
`
`Ex. 2004 Declaration of Joachim Franke, Ph.D.
`
`Ex. 2005 Declaration of Isaac C. Belfer
`
`Ex. 2006 N.G. Das & S.K. Das, Development of Mucoadhesive Dosage Forms
`of Buprenorphine for Sublingual Drug Delivery, Drug Delivery, 11:2,
`89–95, 2004
`
`Ex. 2007 M.S. Surapaneni, S.K. Das & N.G. Das, Effect of Excipient and
`Processing Variables on Adhesive Properties and Release Profile of
`Pentoxifylline from Mucoadhesive Tablets, Drug Development &
`Industrial Pharmacy, 32:3, 377–87, 2006
`
`Ex. 2008 Declaration of Karsten Cremer, Ph.D.
`
`Ex. 2009
`
`Transcript of Deposition of Nandita Das, Ph.D.
`
`
`
`Date: September 17, 2019
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`By / Peter P. Chen /
`David A. Garr
` Registration No.: 74,932
`Peter P. Chen
` Registration No.: 39,631
`COVINGTON & BURLING LLP
`
`Attorneys for Patent Owner
`
`2
`
`
`
`IPR2019-00329
`Patent 9,687,454
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6, I hereby certify that the foregoing Patent Owner
`
`Updated Exhibit List was served by email, by agreement of the parties, on the
`
`following counsel of record for petitioner.
`
`
`
`Ira J. Levy (ilevy@goodwinlaw.com)
`Robert Frederickson III (rfrederickson@goodwinlaw.com)
`GOODWIN PROCTER LLP
`DG-Suboxone@goodwinlaw.com
`
`
`
`
`
`
`
`Date: September 17, 2019
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` / Peter P. Chen /
`Peter P. Chen
`Registration No.: 39,631
`
`
`
`
`
`
`
`
`
`3
`
`
`
`